CORDIS · 101071694 · HORIZON
ATTRACT Phase-1B Breakthrough Innovation Programme for a Pan-European Detection and Imaging Eco-System – Phase-1(B)
Coordinator: ORGANISATION EUROPEENNE POUR LA RECHERCHE NUCLEAIRE (CH)
The ATTRACT Phase-1(B) project delivers an important new angle to the already established and highly regarded ATTRACT Model which created an European eco-system for breakthrough detection & imaging (D&I) technology development based on co-innovation. The precursor H2020 ATTRACT Phase-1(A) and Phase-2 projects have already proven that - in principle - the development of breakthrough innovation from basic science towards market applications does not need to be a matter of chance. It can lead to much faster results if managed and supported consistently through the creation of an trusted ecosyste…
About Horizon Europe (2021–2027)
Horizon Europe is the EU's current research and innovation programme, covering 2021 to 2027 with a budget of roughly €95.5 billion. Its three pillars are Excellent Science (frontier research and mobility), Global Challenges and European Industrial Competitiveness (mission-driven collaborative projects in health, climate, digital, security and food) and Innovative Europe (the EIC and EIT). It also funds five EU Missions targeting cancer, climate adaptation, smart cities, oceans and soils.
EU contribution: €5.0M awarded to the consortium. The project runs over approximately 2.3 years from 2022-11-01 to 2025-01-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from CH
see all →- HBP SGA1 — Human Brain Project Specific Grant Agreement 1720270 · H2020 · €89.0M
- HBP SGA2 — Human Brain Project Specific Grant Agreement 2785907 · H2020 · €88.0M
- ATTRACT2 — Breakthrough Innovation Programme for a Pan-European Detection and Imaging Eco-System – Phase-2101004462 · H2020 · €35.0M
- STEMBANCC — Stem cells for Biological Assays of Novel drugs and prediCtive toxiCology (StemBANCC)115439 · FP7 · €26.0M
- IABC PROGRAMME — iABC Programme115721 · FP7 · €24.3M
- ULTRA-DD — Unrestricted Leveraging of Targets for Research Advancement and Drug Discovery115766 · FP7 · €21.2M
Other HORIZON projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon Europe through a joint programme of the members of the EUROfusion consortium101052200 · DE · €549.4M
- EITUM-BP26-28 — EIT Urban Mobility Business Plan 2026-2028101269525 · ES · €206.9M
- PARC — Partnership for the Assessment of Risks from Chemicals101057014 · FR · €200.0M
- EIT RM BP23-25 — EIT RawMatrials Business Plan 2023-2025101113034 · DE · €155.5M
- SGA1-HE — COST: Europe's most empowering research programme Strengthening science and innovation through research networking101052416 · BE · €153.0M
- EIT HEI — EIT Higher Education Initiative - Scaling Europe’s Innovation Ecosystems101270329 · DE · €130.0M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-RIA funding scheme.
- What is the EU contribution?
- The European Commission contributes €5.0M.
- Which EU programme funds it?
- The project is funded under Horizon Europe (2021–2027), call HORIZON-EIE-2021-SCALEUP-01.
- Who coordinates the project?
- The project is coordinated by ORGANISATION EUROPEENNE POUR LA RECHERCHE NUCLEAIRE (CH).
- What is the project timeline?
- The project runs from 2022-11-01 to 2025-01-31 — approximately 2.3 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101071694.